Join
Live feed
·
INSIDERFilingvia Quantisnow
Vivos Therapeutics Inc. logo

SEC Form 4: Huntsman Ronald Kirk bought $21,550 worth of Common Stock (5,000 units at $4.31), increasing direct ownership by 48% to 15,500 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VVOS (Vivos Therapeutics Inc.) and more on Quantisnow.